GI Biopharma Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 1

GI Biopharma General Information

Description

Developer of inflammatory bowel disease (IBD) treatments designed to solve health problems with dysbiosis. The company's treatments for irritable bowel syndrome and other health problems such as ulcerative colitis associated with dysbiosis of gut microbiota target the potential root cause, enabling patients to get rid of inflammatory bowel disease with probiotics and dietary supplements.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 50 Williams Parkway
  • East Hanover, NJ 07936
  • United States
+1 (908)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 50 Williams Parkway
  • East Hanover, NJ 07936
  • United States
+1 (908)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GI Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 01-Jun-2023 Completed Clinical Trials - Phase 2
To view GI Biopharma’s complete valuation and funding history, request access »

GI Biopharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Westfield BioVentures Accelerator/Incubator Minority
To view GI Biopharma’s complete investors history, request access »

GI Biopharma FAQs

  • When was GI Biopharma founded?

    GI Biopharma was founded in 2014.

  • Where is GI Biopharma headquartered?

    GI Biopharma is headquartered in East Hanover, NJ.

  • What industry is GI Biopharma in?

    GI Biopharma’s primary industry is Drug Discovery.

  • Is GI Biopharma a private or public company?

    GI Biopharma is a Private company.

  • What is GI Biopharma’s current revenue?

    The current revenue for GI Biopharma is .

  • Who are GI Biopharma’s investors?

    Westfield BioVentures has invested in GI Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process